Gland Pharma`s Generic Tranexamic Acid Receives Approval in the U.S
Gland Pharma's Generic Magnesium Sulfate Receives Approval in the U.S
Gland Pharma`s Generic Vasopressin Receives Approval in the U.S.
Gland Pharma`s Generic Nelarabine Receives Approval in the U.S.
Gland Pharma`s Generic Angiotensin II Receives Approval in the U.S.
BENGALURU, Nov 6 (Reuters) - Indian generic injectables maker Gland Pharma (GLAD.NS) posted a weaker-than-expected second-quarter profit on Monday, as higher employee expenses eclipsed strong sales in key markets.
The U.S. Food and Drug Administration U.S. (FDA) has issued a Form 483 to Gland Pharma with two observations after a pre-market inspection of the generic injectables maker’s Pashamylaram facility in Hyderabad.
Gland Pharma's Generic Dihydroergotamine Mesylate Receives Approval in the U.S.
Gland Pharma's Generic Carboprost Tromethamine Receives Approval in US
Gland Pharma`s Generic Argatroban Receives Approval in the U.S.